UK Funds Challenge Trial

Oct 20, 2020

The UK is investing millions of pounds into a human SARS-CoV-2 challenge study in which healthy volunteers will be given the virus in the hopes of better understanding infections and accelerating vaccine development, according to Reuters.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization
Fauna Bio Gets $373K NIH Grant to Study Animal Genomes for Potential Drug Targets
New Products Posted to GenomeWeb: Purigen Biosystems, Zymo Research, Qiagen, More
People in the News: New Appointments at Precipio, ERS Genomics, Omniome, PierianDx, More
In Brief This Week: Invenio Genetics, Swift Biosciences, Caris Life Sciences, and More
Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

The Scan

Letter Urges New Inquiry

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

Great Apes Get Shots, Too

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Woodcock on Vaccines, More

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

Science Paper Examines Molecular Contributors to Kidney Fibrosis

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.

Menu